From: COVID-19 related deaths in an urban academic medical center in Brooklyn – a descriptive case series
White blood cells (WBC) in K/mcL, median (IQR) [ref: 3.5–10.8] (n = 173) | 12·14 (8·84–17·51) |
WBC > 10·8 K/mcL (n, %) | 100 (57·8) |
Absolute lymphocyte count in cells/mcL, median (IQR) [ref: 900–2900] (n = 140) | 800 (500–1100) |
Lymphocytopenia (< 900 cells/mcL) | 87 (62·1) |
Serum creatinine (SCr) in mg/dL, median (IQR) [ref: 0.7–1.3] (n = 147) | 2·2 (1·25–5·25) |
SCr > 1·3 mg/dL (n, %) | 108 (73·5) |
Aspartate aminotransferase (AST) in units/L, median (range) [ref: 13–39] (n = 170) | 63 (41–129) |
AST > 39 units/L (n, %) | 134 (78·8) |
Alanine aminotransferase (ALT) in units/L, median (IQR) [ref: 7–52] (n = 170) | 35·5 (20–68) |
ALT > 52 units/L (n, %) | 53 (31·2) |
Elevation of AST or ALT on expiration (n, %) | |
Mild (2–4.9 x ULN) | 41 (24·1) |
Moderate (5–14.9 x ULN) | 15 (8·8) |
Severe (> 15 x ULN) | 15 (8·8) |
Lactate dehydrogenase (LDH) in units/L, median (IQR) [ref: 140–271] (n = 29) | 645 (522–946) |
LDH > 271 units/L (n, %) | 29 (100) |
C-reactive protein (CRP) in mg/L, median (IQR) [ref: 0–8] (n = 27) | 300 (227·5–337·5) |
CRP > 8 mg/L (n, %) | 27 (100) |
Ferritin in ng/mL, median (IQR) [ref: 14–233] (n = 31) | 2367·7 (516·6–3502·7) |
Ferritin > 233 ng/mL (n, %) | 31 (100) |